Library
3-Me-PCE
3-Me-PCE is the 3-methyl derivative of the internationally controlled substance Eticyclidine (PCE). It shares structural similarities with 3-MeO-PCE and 3-HO-PCE. 3-Me-PCE first appeared in the scientific literature in 2015 in the context of synthesis and analytical caracterization of a series of arylcyclohexylamines by Wallach et al. It is believed to produce ketamine-like dissociative effects predominantly via antagonism of NMDA receptors. Anecdotal evidence of its efficacy dates back to 2022 and assigns it a potency similar to other PCE analogs. The EUDA issued a notification of its first analytical identification in March 2024.
Also known as: N-ethyl-1-(3-methylphenyl)cyclohexan-1-amine
Classification
- Chemical: Arylcyclohexylamine
- Psychoactive: Dissociative
Effects
- Numbness
- Loss Of Balance
- Incoordination
- Stimulation
- Sedation
- Increased Heart Rate
- Disconnection
- Euphoria
- Time Dilation
- Dissociation
- Dizziness
- Anxiety Suppression
- Open Eye Visuals
- Closed Eye Visuals
- Patterning
- Dulled Perception
- Visual Disconnection
- Disinhibition
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
